The future of ophthalmology: Part II

In this second installment, ophthalmologists share how their expectations for "the year of the eye" have compared and contrasted to reality amid the global pandemic.


Alice Epitropoulos, MD, FACS (Cataract and Refractive Center of Ohio), and Dee Stephenson, MD, FACS (president, American Board of Eye Surgery), speak with Ophthalmology Times'® David Hutton on how the use of telemedicine for patient care during the coronavirus pandemic may be the new norm, what's in the lens pipeline, as well as how the expectation versus reality for 2020 in the ophthalmic space have compared.

Watch the first installment here

Related Videos
TENAYA, LUCERNE year 2 data reveals promising results for faricimab
How to diagnose geographic atrophy earlier
World Sight Day 2022: Eye care professionals share what global vision means to them
Samsara Vision update: Concerto trial recruiting patients with late-stage AMD
Understanding fluid dynamics in wet macular degeneration
YOSEMITE, RHINE treat-and-extend data show favorable results for faricimab for the treatment of DME
What are you most excited about in the field of retina? Tunde Peto, MD, PhD weighs in
© 2023 MJH Life Sciences

All rights reserved.